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Abstract: Sensitive and specific DNA biomarker detection is critical for accurately diagnosing a
broad range of clinical conditions. However, the incorporation of such biosensing structures in
integrated microfluidic devices is often complicated by the need for an additional labelling step
to be implemented on the device. In this review we focused on presenting recent advances in
label-free DNA biosensor technology, with a particular focus on microfluidic integrated devices.
The key biosensing approaches miniaturized in flow-cell structures were presented, followed by
more sophisticated microfluidic devices and higher integration examples in the literature. The option
of full DNA sequencing on microfluidic chips via nanopore technology was highlighted, along with
current developments in the commercialization of microfluidic, label-free DNA detection devices.
Keywords: DNA; biosensor; label-free; microfluidics; Lab-on-Chip
1. Introduction
The rapid technological progress of the past couple of decades in the fields of biosensors and
microfluidics [1], has allowed the originally envisioned democratization of healthcare of the early
1990s [2] to be closer to realization than ever. A broad range of different biosensing concepts and
microfluidic structures currently allows the qualitative or quantitative detection of various biomarkers
of clinical interest. With DNA biomarkers [3,4] increasingly being identified and associated with a
very broad spectrum of clinical diseases (e.g., cancer, infectious disease, antimicrobial resistance, etc.),
intense scientific effort has been focused on their sensitive and specific detection. With the ultimate
goal being affordable, easy to use and small footprint DNA diagnostic microsystems, microfluidic
structure integration for sample pre-processing and automated reagent handling are some of the
critical aspects being investigated currently [5]. Simplicity in device functionality is critical, aspiring
for robust and reliable diagnostic microsystems; to this end, simplification of the biosensing assay by
removing the need for any additional labelling step [6,7] can provide a step-change in the development
of tests ready for mass deployment.
Therefore, in this review our goal is to present recent developments in label-free DNA biosensors,
with a particular focus on integration with microfluidic structures. We classified the microfluidic
devices based on the integrated microfluidic structure complexity, starting from the simplest approach
of flow-cell integration. Given the number of interesting flow-cell integrated structures, they were
sub-classified using the biosensing principle employed. We then proceeded to more complicated
microfluidic structures for label-free DNA biosensing platforms, higher integration examples,
and state-of-the-art nanofluidic-based DNA sequencers. We conclude with the commercialization
efforts currently being pursued in the field. It is worth noting that our definition of label-free detection
involves techniques that do not require the attachment of any additional molecule on the target
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DNA sequence; hence techniques involving the use of reagents diluted in solutions for measurement
purposes, are still considered to be label-free.
2. Flow-Cell Biosensing Approaches
Over the past two decades label-free biosensing has seen an unprecedented development in
advancement from macro, to micro, to nanotechnology [8]. This improvement in the miniaturization
of sensing technology would not have been possible without the integration of microfluidics [9].
Nonetheless, the field of biosensing still has a long way to go to meet the requirements of
commercialization, for application in bed-side diagnostics [10]. Technologies for the label-free
detection of DNA hybridization utilizing microfluidic structures to deliver the analytes exploit optical,
electrochemical, as well as mass-based sensing concepts.
2.1. Optical
Optical approaches in biosensing are a promising area of analysis tools, which have received
considerable research interest for label-free DNA detection. The advantages of optical biosensing
systems include not only their inherent resistance to electromagnetic interference, but also their low
limits of detection (LOD) at both the micro and nano scales, and the ability to perform multiple analyte
detections within a single Lab-on-Chip (LOC) device [11–13].
Surface plasmon resonance (SPR) is the most well-known optical technique for real-time, label-free
characterization of binding kinetics and affinity. It involves the determination of the resonant oscillation
of conduction electrons at the interface between negative and positive permittivity material, stimulated
by incident light. The first SPR biosensing device demonstrated by Liedberg et al. in 1983 [14],
established SPR as an important optical method for the detection of bio-recognition molecules.
The last decade has seen extensive studies of this now ubiquitous laboratory technique, as well
as the development of a number of SPR devices for DNA hybridization detection [13].
In 2017 Yuan et al. [15] demonstrated the use of a highly sensitive label-free SPR-DNA
sensor utilizing in situ synthesized copper nanoparticles (CuNPs), by terminal deoxynucleoside
transferase (TdT)-mediated DNA prolongation form-logic ideology (Figure 1). Using this method,
a highly-sensitive LOD of 3.2 fM was achieved under flow-injection rates of 10 µL min−1.
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Figure 1. Schematic drawing of the synthesis of CuNPs templated by TdT-mediated DNA (Reprinted
from Yuan et al. [15]. Copyright (2017), with permission from Elsevier).
The development of an SPR-based sequence-specific microfluidic chip was reported by Kurita et al.
in 2015 [16], for the immunochemical detection of DNA methylation. The group reports the use of an
affinity measurement involving a target (methyl)-cytosine, within a single-base bulge region. The target
was flowed through a microfluidic channel containing anti-methylcytosine antibody, followed by
hybridization with a biotinylated bulge-inducing DNA probe on the surface of gold. Results showed
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significantly high DNA methylation assessment (6 amol or 48 fg); they also discriminated between the
methylation status of single cytosine in genomic λ DNA and HCT116 human colon cancer cells.
Localized surface plasmon resonance (LSPR) is another approach that has received attention
due to its advantage of localized-field phenomenon, which allows for lower levels of background
interference. Unlike SPR, LSPR instrumentation is also less complex, not requiring a prism or a grating
coupler for excitation of propagating plasmons [13]. This low complexity of instrumentation allows
for the increased portability and miniaturization of LSPR sensors, as well as cost effectiveness [17].
Another study by Huang et al. in 2012 exploited the characteristic LSPR properties of gold
nanorings in an on-chip microfluidic device, for the real-time detection of label-free DNA. Single-
stranded DNA (ssDNA) probes were immobilized onto the surface of the sensor. Complementary
target DNA was then passed through two inlets into a sensing chamber to be analyzed using LSPR,
before passing through to waste reservoirs, and finally out of the device through two outlets. Using this
method of gold nanorings, a wavelength shift of 8.2 nm was observed upon DNA probe immobilization,
followed by a 3.1 nm shift after DNA hybridization. Thus, effectively coupling both a label-free
nanosensor technique with a microfluidic platform. Interferometric techniques, such as bimodal,
Mach-Zehnder, and micro ring resonators, could also be used for label-free DNA detection [18–20].
Song et al. 2016 [19] reported a microfiber-assisted Mach-Zehnder interferometer (MAMZI) for
label-free DNA detection. The interferometric spectrum of the proposed microcavity sensor was highly
sensitive to variation of the environmental refractive index (RI), and could be applicable for most
biological applications.
Surface-enhanced Raman spectroscopy (SERS) based microfluidic platforms have also been
presented in the literature, referred commonly as lab-on-chip SERS (LoC-SERS) or nano/micro/
optofluidic SERS [21]. A growing number of applications of microfluidic SERS analysis related to DNA
biosensing has been developed [22], citing its extraordinary sensitivity towards different targets in a
large range of concentrations, exploiting nL volume samples. Qi et al. [23] presented a microfluidic
SERS system, approaching single molecule sensitivity when monitoring DNA hybridization. Current
efforts focus on specific multiplex detection of small oligonucleotides, by improving the SERS substrate
properties with nanotechnology [24].
2.2. Electrochemical
Recently, electrochemical biosensors have become one of the biggest and most studied approaches
to biological sensing [8,25,26]. This is due to their low levels of detection, inexpensive running costs,
and simple instrumentation relating to ease of miniaturization, making electrochemical methods highly
attractive for the development of point-of-care diagnostic devices.
A Bio-FET is a field-effect transistor (FET), which is gated by the surface potential change induced
by the binding of (bio)molecules. Devices based on field-effect transistors have attracted great attention
because they operate as an intrinsic amplifier, converting small changes in surface potential to large
changes in the current without the need for additional circuitry. The dielectric material (FET gate
dielectric) changes the charge distribution of underlying semiconductor materials when biomolecules
bind to the FET dielectric or gate electrode, resulting in a change in conductance. Moreover, no labeling
step is required for Bio-FET, making it more suitable for point-of-site detection, such as medical
diagnostics, biological research, environmental monitoring, and food analysis because of its low
weight, low cost of mass production, small size, compatibility with commercial planar processes for
large-scale circuitry, and possibility of integration into microfluidic devices for Lab-on-Chip [27].
An example of a microfluidic integrated label-free DNA FET was created by Xu et al. [28] on
a printed circuit board. An 8-channel FET DNA sensor array was fabricated from chemical vapour
deposition (CVD) graphene, and each graphene site in the array was used for two purposes: First, as
a sensing FET, and second, as an electrophoretic electrode to enable site-specific immobilization of
probe DNA (Figure 2). The site-specific single-stranded target DNA was detected in the femtomolar
level (LOD = 100 fM) upon hybridization, and each graphene was used as a FET. By using an
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8-graphene-electrode/FET array with a microfluidic channel on top, it makes the device suitable
for multiplex DNA detection.
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Figure 2. (a) Image of an 8-graphene-electrode/FET array with a microfluidic channel. (b) A cross-
sectional view of an individual graphene site. (c) Optical image of a fabricated graphene array.
(d) Schematic illustration of site-specific probe DNA immobilization and target detection. (I & II)
BSA–streptavidin surface functionalization, (III) non electrophoretic probe DNA immobilization, and
(IV) hybridization or control experiments (Reprinted from Xu et al. [28]. Copyright (2014), with
permission from Springer Nature).
Electrochemical impedance spectroscopy (EIS) is a ubiquitous characterization technique used in
biosensing laboratories to detect the non-linear response of an electrochemical system to an applied
potential, revealing underlying biological recognitions events.
An example of an EIS-based system was demonstrated by Ben-Yoav et al. [29], who developed
a microfluidic EIS-based biochip for the detection of DNA hybridization (DNA/DNA). The biochip
was composed of three micro-channels on an arrayed electrochemical micro-chip (Figure 3). Probe
ssDNA was immobilized on both gold and platinum, using mercaptohexanol (MCH) as a back-filler.
Target ssDNA was then exposed to probe ssDNA under flow within a [Fe(CN)6]3−/4− redox couple in
phosphate buffered saline (PBS) solution. Using this method, a LOD of 3.8 nM, and a selectivity of 13%
hybridization with other non-complementary DNA was demonstrated.
Chemosensors 2018, 6, 43 5 of 20
Chemosensors 2018, 6, x  5 of 19 
 
 
Figure 3. Tested microfluidic device (dimensions: 3.5 cm × 3.5 cm; micro-channel height of 100 µm, 
width 500 µm) (Reprinted from Ben-Yoav et al. [29]. Copyright (2012), with permission from Elsevier). 
Open circuit potential (OCP) utilizes the change in the net charge of an electrode surface. A study 
by Jolly et al. [30] implemented both OCP and EIS to detect PNA/DNA hybridization with sample 
amplification by gold nanoparticles (AuNPs). Peptide nucleic acid (PNA) probes, used for their 
inherent neutral charge, were immobilized onto the surface of a gold working electrode. PNA/DNA 
hybridization was then measured by OCP and EIS in real-time with a three electrode set-up  
(Figure 4). Using the current system, a LOD of 1 fM was achieved with significant increases in 
capacitance due to use of AuNPs. 
 
Figure 4. Open circuit potential (OCP) measurements of PNA/DNA hybridization in real-time  
(© [2015] IEEE. Reprinted, with permission, from Joly et al. [30]). 
A label-free EIS-based biosensor chip was demonstrated by Wu et al. 2015 [31], for the detection 
of DNA hybridization. This device was integrated with microfluidic DC-biased AC electroosmotic 
(ACEO) stirring, utilizing concentric double ring-single disk electrodes to increase hybridization 
events. Thiol-modified probe DNA was immobilized onto the surface of gold disk electrodes (DE) to 
Figure 3. Tested icrofluidic device (di ensions: 3.5 c × 3.5 c ; icro-channel height of 100 µ ,
idth 500 µ ) (Reprinted fro Ben-Yoav et al. [29]. Copyright (2012), ith per ission fro Elsevier).
t
[ ] i l t t an EIS to detect PNA/
fi Peptide nucleic aci ( ) ,
i ili t t s rface of a gold orking electrode. P /
was then measured by OCP and EIS in real-time with a three electrode set-up (Figure 4).
Using the curre t system, a LOD of 1 fM was achieved with ignificant increases in capacitanc due to
use of AuNPs.
Chemosensors 2018, 6, x  5 of 19 
 
 
Figure 3. Tested microfluidic device (dimensions: 3.5 cm × 3.5 cm; micro-channel height of 100 µm, 
width 500 µm) (Reprinted from Ben-Yoav et al. [29]. Copyright (2012), with permission from Elsevier). 
Open circuit potential (OCP) utilizes the change in the net charge of an electrode surface. A study 
by Jolly t al. [30] implemented both OCP and EIS to detect PNA/DNA hybridization with sample 
amplification by gold nanoparticles (AuNPs). Pep ide nucleic acid (PNA) probes, used for their 
inherent neutral charge, were immobilized onto th  surface of a gold working electrode. PNA/DNA 
hybridization was then measured y OCP and EIS in real-time with a thr  electrode set-up  
(Figure 4). Using the current system, a LOD of 1 fM was chiev d with significan  incr as s in 
capacitance du  to u  of AuNPs. 
 
Figure 4. Open circuit potential (OCP) measurements of PNA/DNA hybridization in real-time  
(© [2015] IEEE. Rep inted, with permission, from Joly et al. [30]). 
A label-free EIS-based biosensor chip was demonstrated by Wu et al. 2015 [31], for the detection 
of DNA hybridization. This device was integrat d with microfluidic DC-biased AC electroosmotic 
(ACEO) stirring, utilizing concentric doubl  ring-single disk electrodes to increase hybridization 
events. Thiol-modified probe DNA was immobilized onto the surface of gold disk electrodes (DE) to 
Figure . potential (OCP) measurements of PNA/DNA hybridization in real-time (©
[2015] IEE . R printed, with permiss on, from Joly et al. [30]).
A label-free EIS-based biosensor chip as de onstrated by et al. 2015 [31], for the detection
of ybridization. This device as integrated ith icrofluidic -biased C electroos otic
( ) stirri g, utilizing concentric double ring-single disk electrodes to incre hybridiza i n events.
Chemosensors 2018, 6, 43 6 of 20
Thiol-modified probe DNA was immobilized onto the surface of gold disk electrodes (DE) to form
Au-S bonds. Target DNA was then hybridized under ACEO stirring and measured using EIS and
OCP. EIS was used to measure changes upon DNA hybridization, and OCP for characterization of
the probe-MCH layer. Using this method, a detection range of 1 aM–10 pM with good linearity was
demonstrated, alongside an ultrasensitive LOD of 0.5 aM. Furthermore, a 90% hybridization saturation
was achieved using the ACEO stirring method within 141 s.
2.3. Mass-Based
Another approach to biosensing, which has seen less recent activity in microfluidic research, is the
mass-based signal transduction methods (for example, quartz crystal microbalance (QCM) and surface
acoustic waves (SAW)). These methods are unique in biosensing, as they rely on the change in mass
occurring when a target analyte binds to an immobilized probe. The major advantages of mass-based
sensors are the high sensitivity and robustness with which they detect biological recognition events,
making them suitable for detection at the micro and nano level [8].
An example of the robust nature of mass-based sensors was presented by Hong et al. in 2010 [32],
comprising a QCM biosensor integrated with piezoelectric wafer layer wells and syringe pumps,
for label-free detection of viral hemorrhagic septicemia (VHS). DNA probes were immobilized onto the
gold-coated quartz surface of the sensor using different thiol, amine, and biotin 3′ modifications,
to maximize sensitivity. Both target complementary DNA and mismatched DNA was flowed
through the wells using a syringe pump (flow rate of 25 µL/min) during measurement. Results
showed immobilization with biotin to be the most effective for both immobilization and detection
of target DNA, with a LOC of 1.6 nM. The system using biotinylated probe DNA also showed high
stability, withstanding 32 repeated regenerations without any significant reduction in signal generation
(Figure 5).
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García- artinez et al. [33] developed a 50 z quartz crystal icrobalance (QC )-based sensor
for D A utilizing fluid circulation for high selectivity and limit of detection (LOD). Oscillator circuitry
based on Miller topology was used ith circulatory flow to calibrate and detect background frequency
noise and allow for high resolution (7.1 ng/cm2 under flow conditions in this study). DNA-disulfide
probes were immobilized onto the gold-quartz surface within 0.5 M NaCl solution. DNA target was
then hybridized under flow, followed by dehybridization solution (0.5 M NaOH, 3 M NaCl) (Figure 6).
The study proved the DNA biosensing capabilities of the QCM oscillator with a LOD of 50 ng/mL.
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Crystal Microbalance (QCM)-Based DNA Biosensor Using a 50 MHz Electronic Oscillator Circuit”
under Creative Commons 4.0 license).
Surface acoustic wave (SAW) devices involve mechanical waves formed on the surface of a
piezoelectric crystal. SAW-based sensors have been shown to be highly selective of bio-recognition
events [34,35]. However, studies implementing SAW for detection of DNA with high optimized
frequencies are limited. Nonetheless, SAW-based devices may have the opportunity to become a
major player with the prospective commercialization of medical devices that require highly sensitive,
selective, and cost-effective analysis [36].
A recent study by Zha g et al. [37] roposed the use of mass-sensitive SAW technology, for the
detection of amplified and sequence-specific DNA hybridization utilizing enzyme-mediated DNA
elongation with silver nanoparticle synthesis in situ (Figure 7). Target DNA was hybridized with
gold-immobilized probe DNA oligonucleotides (flow rate of 40 µL/min). Target DNA interacted with
terminal deoxynucleoside transferase (TdT) and deoxy-ribonucleoside triphosphate (dNTP) causing
prolongation. The prolongation template DNA then binds with Ag+-binding DNA. Accumulated Ag+
ions then nucleated to form AgNPs. These two reactions caused a highly measurable mass increase
and the synthesis of AgNPs decreasing LOD. Results suggested high sequence-specificity, even in
the presence of single stranded mismatched DNA in single nucleotide polymorphism (SNP) assays.
A value of 0.8 pM was achieved for LOD due to signal amplification by AgNPs.
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3. Microfluidic Modules for Sample Preparation
The simplest microfluidic devices integrated with label-free DNA biosensors comprise the
previously analyzed approach of flow cell chambers, or channels that allow the continuous flow
analysis of a pre-processed DNA sample. However, the true advantage of integrating microfluidic
components with a DNA biosensor is leveraged when the sample can be pre-processed on-chip,
with the incorporation of the necessary modules. In the case of DNA detection, the first sample
preparation step required is the extraction of the specific DNA that needs to be detected. Depending
on the sensitivity of the biosensor and the concentration of the target DNA within the sample, a DNA
amplification step may also be required. Moreover, when the application requires very high throughput
analysis, droplet microfluidic devices have proved to be very promising, allowing the implementation
of the complete assay within a few nL liquid compartments.
3.1. DNA Extraction
DNA extraction microfluidic modules [38] are involved with releasing the target DNA from the
cells of interest, using a variety of techniques to this end. Extracting the required DNA is currently
a basic molecular biology laboratory technique [38,39], with several commercial kits in the market
for standard laboratory use. The process can be roughly divided into four steps [40], which can be
modulated depending on the sample and downstream applications: (i) Cell disruption; (ii) removal of
membrane lipids, proteins, and other nucleic acids; (iii) nucleic acid purification/binding from bulk;
and (iv) nucleic acid concentration. The advantages of using microfluidics for these processes involve
the automation of laborious and time-consuming laboratory processes, minimizing human-handling
errors or cross-contamination. It also allows for their integration with DNA detection modules to
realize a sample-in-answer-out Lab-on-Chip device.
The first efforts in DNA extraction microfluidic modules involved the adaptation of benchtop
DNA extraction protocols [41–46] in a microfluidic device. The main challenges faced by these early
examples included the need to handle multiple chemical reagents in multistep assays, along with the
transfer of reagents between solid and liquid phases. Furthermore, it is worth noting that care needs to
be taken on the extraction reagent selection, so that they do not inhibit any subsequent amplification
or detection steps [47].
Another very interesting microfluidic implementation involves the utilization of magnetic
particles. For example, Karle et al. [48] cultured the bacterium Escherichia coli in a magnetic bead
suspension, along with lysis and binding buffers, resulting in the bacterial DNA being extracted and
attached on the magnetic bead surfaces (Figure 8). The DNA-carrying beads could then be directed
at will within the chip using a rotating permanent magnet. This approach significantly simplifies
the designed chip and fluidic handling steps required. One of the most commercially successful
implementations of a DNA extraction microfluidic module is found in the GeneXpert MTB/RIF [49].
In this system, the cells of interest are isolated from the sample though filtration, and their DNA is
released via sonication.
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their implementation in paper-based microfluidic devices (Figure 9), particularly suited for use in
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4. Higher Integration Platforms
With the realization of all the previously reported efforts, the true potential of Lab-on-Chip
technology can be realized in sample-in-answer-out devices. The whole analytical procedures described
earlier (including sample pretreatment, sample manipulation, separation, reaction, and detection),
can be integrated into a single chip platform. Over the past years, several partially integrated systems
have been presented in literature, with increasing complexity and degree of integration in more
recent studies. An in situ electrochemical (EC) detection method in a microfluidic flow-through
EC-quantitative PCR (FTEC-qPCR) device was developed, where both the target DNA amplification
and subsequent EC detection of the PCR amplicon were performed simultaneously in the same
device [55]. An electroactive reporter (methylene blue) was used for in situ EC detection of the
PCR amplicon. Woolley et al. demonstrated an integrated microfluidic device, which permitted
the direct integration of microfabricated PCR and capillary electrophoresis (CE) components on a
single micro-device [56]. The rapid thermal cycling capabilities of microfabricated PCR devices with
high-speed DNA separations provided by microfabricated CE chips, was the critical microfluidic
addition. A microfabricated device for cell isolation was presented by Wilding and co-workers [57],
with the benefit of integrating whole blood sample preparation on-chip for subsequent nucleic acid
amplification. White blood cells were isolated from whole blood in silicon–glass microchips using
filters, formed by an etched silicon dam spanning the flow chamber. The direct DNA amplification
was done using polymerase chain reaction from the white cells isolated on the filters. Papadakis et al.
2018 [58] reported a micro-nano-bio acoustic system for the detection of foodborne pathogens in real
samples with a highly integrated microfluidic system. The authors used immuno-magnetic beads to
capture cells, and subsequently demonstrate efficient DNA amplification using the Loop Mediated
Isothermal Amplification method (LAMP) and acoustic detection in an integrated platform. However,
there was still a need to further integrate more of the required detection steps in a single microfluidic
chip. Liu et al. presented a highly integrated plastic monolithic device, where PCR amplification,
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DNA hybridization, and a post-hybridization wash have been integrated in a single, low-cost,
disposable monolithic device, containing all of the necessary fluidic channels and reservoirs [59].
Very recently, Nguyen et al. developed a unique highly integrated microfluidic device, performing not
only the amplification of DNA of Salmonella spp. within 30 min, but also the immediate subsequent
measurement of DNA amplicon by the SPR fiber sensor part [60]. The novelty was the integration of
a polymerase chain reaction (PCR) microdevice and a surface plasmon resonance (SPR) optical fiber
sensor into an inline all-in-one device (Figure 10). The authors proposed that the detection instrument
could be further miniaturized by incorporating a miniaturized light source/photodiode.
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Another multiplexed integrated label-free DNA detection platform was proposed by including
two functional modules, i.e., a multiplexed PCR module for amplification of nucleic acid targets,
and a multiplexed silicon nanowire (SiNW) module for sequence determination [61]. The PCR module
consisted of a microfluidic PCR chamber and an electrical controller. A control SiNW was implemented
to eliminate background interference. The detection module demonstrated a 10-fold change in the
magnitude of differential current when the target DNA was injected. The low sample consumption,
high sensitivity, and high specificity, rendered it a potential point-of-care (POC) platform to assist
doctors in reaching a yes/no decision for infectious diseases.
To eliminate the time-consuming PCR step, Medina-Sánchez et al. reported an ultrasensitive
label-free DNA biosensor with fully on-chip integrated rolled-up nanomembrane electrodes, for avian
influenza virus subtype H1N1 DNA detection, with an attomolar detection range for miniaturized
sensors without amplification. The electrodes were prepared via sequential deposition of strained
nanomembranes onto a sacrificial layer, which was then selectively dissolved, resulting in the
self-roll-up of the microtubular electrodes [62].
Haber et al. [63] recently integrated on-chip DNA hybridization and real-time PCR using
an LSPR-based sensor. They outlined the development of a novel microfluidic sensor for the
implementation of qPCR, employing a piezo-electric pumping microsystem. Complementary DNA
probes were immobilized onto the surface of nanoprisms on the surface of glass attached via
poly-L-lysine linkers. DNA hybridization was then measured using label-free LSPR imaging for
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real-time results (Figure 11). A limit of detection of 5 fg/µL was demonstrated for E. coli DNA
(approximately 300 bacteria per mL). Detection of target DNA was achieved within 15 min of PCR
initiation, which promises the type of rapid diagnosis required for POC devices.
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Droplet-based microfluidics are also an id al integration platform for applications requiring
high-throughput analysis [64]. These systems offer the unique advantages of automated
compartmentalization of reagents in multiple picoliter volume drops, along with the possibility
to perform in a programmable way, multiple combinations of reagents rapidly. Many such platforms
have been integrated with label-free biosensors. Indicatively, Malic et al. [65] incorporated Surface
Plasmon Resonance Imaging (SPRi) DNA sensors, achieving 500 pM LOD. Hsieh et al. [66] employed
a molecular beacon fluorescence detection approach achieving 500 fM LOD, whilst Ebrahimi et al. [67]
integrated non-Faradaic electrochemical impedance spectroscopy biosensors in a droplet microfluidic
platform, reaching aM-scale DNA detection.
5. Nanopore Technology for Label-Free DNA Sequencing
Nanopore-based systems are nanofluidic devices for label-free sequencing of DNA molecules,
drawing inspiration from the biological nanopores present in cellular membranes [68]. The physical
concept can be accurately described as a micro-Coulter counter for DNA bases; where a voltage is
applied between the nanopore inlet and outlet, and the polynucleotide bases passing through the pore
modulate the ionic current proportionally, allowing the sequential identification of each base in the
analyzed strand.
The first nanopore sensor mimicked this natural presence of nanopores in biological membranes
(Figure 12), embedding a single α-hemolysin protein in a lipid bilayer to exploit its inner diameter
compatibility with DNA molecules. Solid state nanopores (e.g., SiNx, SiO2) soon substituted the
biological original protein nanopores, owing to the instability of the supporting lipid bilayer under
chemical, electrical, or physical variations. The introduction of solid state nanopores also allowed
more versatility in their fabrication, enabling variable but controlled diameters and geometries, even
in sub-nanometer resolutions.
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This advancement towards solid state nanopores has given rise to a variety of nanofabrication
efforts [69] exploiting different material properties, aiming to achieve the optimum nanopore
resolution, thickness, and reduction of DNA passage speed through the nanopore. The combination
of e-beam lithography with reactive ion etching, focused-ion beam, and heliu ion beam methods,
have been presented in literature with impressive results. Currently, the prevailing technique lies with
transmission electron microscopy (TEM) focused ion beam, allowing real time control of nanopore
formation in the order of 2 nm diameters. Another interesting alternative fabrication technique involves
glass capillary nanopores (also known as glass nanopipettes) [70,71]. This approach proves particularly
advantageous in terms of stiffness, manufacturability, and cost-effectiveness, with shrinking of the
device, making it ideal for DNA translocation studies [72].
The nanofabrication of a complete, high performing nanopore-based DNA sequencing system is
currently the main focus of researchers [73,74], with the objective of combining solid state nanopores,
sensing nanoelectrodes for the detection of the electrical signal and sample delivery nanofluidics
into a rapid and reliable DNA sequencing microchip. The commercial success of Oxford Nanopore
Ltd. (see the following paragraph), launching MinION as the first portable commercial label-free
sequencer [75], has led researchers to assess its performance in several real-life applications, and to try
to identify its current limitations [76–78]. The initial results look very promising in terms of throughput
and analysis time, nonetheless, further technological development is required to reduce the error rate
to match benchtop equip ent performance.
6. Commercial Systems
In the commercial arena, one of the most widely used techniques for label-free biosensing of DNA
is IonTorrent, now part of Thermo Fisher Scientific, which uses semiconductor technology for DNA
sequencing. The process involves the library preparation by DNA fragmentation and attachment to a
magnetic bead, where a single fragment is amplified. Beads carrying copies of label-free ssDNA are
loaded onto the sequencing chip, where each of the beads is captured in an individual well containing a
miniaturized ion-sensitive field-effect transistor (ISFET) pH sensor. The chip is flooded with a solution
containing a single nucleotide type and where a match is present, the nucleotide is incorporated,
releasing a hydrogen ion which lowers the pH of the solution in the well, and is detected by the built-in
ISFET. If more than one base is present in succession, the signal gets proportionally higher. Different
nucleotide solutions are sequentially introduced onto the chip, enabling the sequence determination.
Millions of wells are simultaneously recording nucleotide incorporation, enabling parallel reading and
massive scalability [79,80]. IonTorrent technology is currently covering multiple applications from
targeted DNA sequencing, microRNA sequencing, to bacterial and viral typing [81].
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Oxford Nanopore Technologies, a spinout from the University of Oxford, brought sequencing
technology to its users as a USB powered pocket-sized device called MinION. To start off, a DNA
library can be prepared in 10 min, and data can be observed in real time during sequencing. After
commercialization of MinION in 2014, the GridION and PromethION systems have been developed,
enabling up to 5 and 48 parallel MinION flow cells, respectively [82]. The MinION device has been
used to sequence human genome [83], and has been especially useful in monitoring epidemic diseases
at remote locations, due to is portability and sequencing speed [84]. The company is currently working
on an even smaller portable device, which will be able to perform sequencing whilst connected to a
smartphone [82].
In the effort to bring nucleic acid detection to remote locations, QuantuMDx is developing the
Q-POCTM, a handheld device compatible with disease specific cartridges [85], capable of sample
preparation, DNA extraction, amplification, and detection in 10–20 min, from multiple biological
samples [86]. They envision a wide area of applications, ranging from drug resistance analyses for
tuberculosis, infectious disease identification, such as STIs and HPV, to metabolism genotyping to
identify the optimal warfarin dosage [87]. The company is developing two detection approaches [88]:
An optical based strategy using fluorescent markers and an electrochemical one, based on label-free
nanowire field effect transistors [89]. One of their goals is to create a world-wide map to monitor
pathogen evolution, in the effort to prevent global outbreaks [86]. To achieve this, they are aiming
to use nanowire FETs to sequence pathogens DNA in a portable device [89]. However, to the best
of our knowledge, the Q-POCTM device, which is planned to be launched in 2018, uses fluorescence
detection [86].
Another company trying to reach the diagnostic market is Atlas Genetics, a spinout from the
University of Bath, which offers their CE-marked io® system for detection of STIs and other infections.
The io® instrument is a benchtop device, in which a single-use cartridge is inserted, and the result is
obtained within 30 min. First, the sample is introduced into the cartridge, where DNA is extracted
and amplified via PCR [90]. The detection chamber includes target complementary probes, linked to a
ferrocene tag and a double strand specific nuclease [91]. When a label-free target DNA hybridizes with
a detection probe, nuclease cleaves off the ferrocene tag, which is detected electrochemically, using
differential pulse voltammetry [92]. Including multiple detection chambers in a single cartridge, and
engineering ferrocene labels and their electrochemical properties [93], grants the io® system a high
capacity for multiplexing. They have published multiple studies using clinical material for diagnosis
of pathogenic Candida species [94,95], Chlamydia trachomatis [96], and Trichomonas vaginalis [97].
Recently DNAe, a spin-out from Imperial College London, presented a semiconductor sequencing
based benchtop device called LiDiaTM, which can accurately detect pathogen DNA and identify from
bloodstream infections to antimicrobial resistance. During the process, the blood sample is introduced
into a disposable cartridge and loaded to the reader. Target extraction, concentration, and isolation,
along with genomic analysis on a chip is performed in a single cartridge [98]. The amplification reaction
occurs on the chip integrated with embedded heaters and ISFETs. As specific primers recognize the
label-free target DNA, the amplification reaction initiates. With each nucleotide being incorporated to
an amplicon, a proton is released, lowering the pH in the solution. Therefore, amplification reaction is
detected in real time by the ISFET [99]. DNAe are currently testing the device with clinical samples
with a plan for CE application in 2018. One of their main applications is detection of sepsis, where
their device can provide information about the appropriate antimicrobial treatment within 3 h [98].
7. Conclusions and Future Outlook
In this article, we reviewed recent technological progress in the field of microfluidic-assisted
label-free DNA biosensing devices. We mainly focused on label-free highly integrated biosensor
devices, which are suitable for point-of-site detection, such as medical diagnostics, biological research,
environmental monitoring, and food analysis. Optical, electrochemical, mass-based label-free
biosensing approaches are currently being pursued for microfluidic integration, each featuring
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particular advantages and disadvantages. Mass-based methods can provide very efficient detection for
heavier molecules, nonetheless, they can prove less competitive for smaller molecules, such as short
chain oligonucleotides. On the other hand, optical approaches can provide very low-limits of detection
even for very small molecules; however, they suffer from their elaborate instrumentation requirement
in terms of platform miniaturization. Electrochemical biosensors offer the advantage of combined low
limits of detection and minimal, low-power instrumentation requirements. All sample preparation
microfluidic modules enabling a sample-in-answer-out system (i.e., cell-isolation, DNA extraction,
DNA amplification), have been individually demonstrated in the literature; nonetheless, very few
efforts for multiple module integration have been reported so far. Multiplexed DNA amplification
modules, droplet-based microfluidics, and nanopore-assisted sequencing, clearly indicate the technical
feasibility of high-throughput and high specification portable systems in the future. Currently via
nanopore technology, it is possible to have DNA sequencing at the point-of-need, at a throughput
of 10–20 G bases per 48 h. Whilst such a sequencing throughput is impressive, there are numerous
diagnostic applications where full genome sequencing is not required. In such cases, microfluidic
platforms offering sample-in-answer-out operations, with time to result of a few minutes, may prove
more practical in real-life practice, both for Point-of-Need use in Centralized healthcare systems and
for low-resource settings.
Building on more mature technologies in microfluidic DNA systems, several commercial efforts
are already promising to launch in the immediate future sample-in-answer-out systems, with specific
medical diagnostic applications. A major challenge to be overcome pertains to the cost-effective
integration of highly sensitive biosensors in portable devices, or even in equipment-free systems. At the
moment, a seamless mass-manufacturing approach for integration of all the required components is
not commercially available, with each diagnostic company pursuing their own strategy. Moreover,
the exploitation of sensing approaches requiring elaborate or expensive instrumentation can present
obstacles in portability, along with the large power requirements associated with heating on modules
incorporating DNA amplification. With most practical applications demanding the quantification of
multiple DNA strands simultaneously, both assays and devices allowing multiplexed detection need to
be developed. Finally, device development should be carried out based on real physiological samples
early on, assuring device compliance with international regulatory frameworks and biomedical
device standards.
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